Patent · US Active

CCR2 receptor antagonists and uses thereof

US8653262B2 · kind B2 · utility

0Cited by

17References

4Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Heiner Ebel · Biberach an der Riß, DE
Silke Hobbie · Biberach, DE

Key dates

Filing date	May 29, 2008
Grant date	Feb 18, 2014
Priority date	—
Expiry date	Jan 23, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.